Key result
In obese individuals, excessively low levels of insulin resistance (HOMA2-IR ≤ 1.0) were associated with a significantly higher risk of cardiovascular mortality compared to moderate levels (HR 1.82).
Why the study?
The association of HOMA2-IR and mortality among obese and non-obese populations has not been clearly explained.
Does HOMA2-IR level associate with all-cause and cardiovascular mortality in obese and non-obese individuals?
Cohort (n=7,085)
Does HOMA2-IR level associate with all-cause and cardiovascular mortality in obese and non-obese individuals?
Hazard Ratio: 1.82 (95% CI 1.14–2.92)
Absolute Event Rate: 11.9% vs 6.4%
p-value: p=0.013
While elevated HOMA2-IR is associated with increased mortality, excessively low insulin resistance also correlates with higher cardiovascular mortality in obese individuals, demonstrating a U-shaped relationship.
May signal higher CV mortality risk in obese patients; leaves open causal mechanisms and need for prospective validation.
Background The association of homeostatic model assessment (HOMA2-IR) and mortality among obese and non-obese population has not been clearly explained so far. Methods A total of 7,085 individuals aged ≥ 20 years from the National Health and Nutrition Examination Survey 1999–2006 were included in the study. The study endpoints were all-cause and cardiovascular mortality. Multivariate Cox proportional hazards regression models, restricted cubic spline analysis and Kaplan-Meier curve were employed for the evaluation. Results In a study comprising 59,815,733 weighted eligible participants, a total of 1666 all-cause deaths and 555 cardiovascular (CV) deaths were recorded over a mean follow-up period of 195.53 months. Notably, a significant difference in obesity was observed in relation to the association between HOMA2-IR and mortality. Upon adjusting for multiple variables, the highest group of HOMA2-IR exhibited an increased risk of all-cause and CV mortality among non-obese individuals when compared to the middle group. Conversely, the lowest group of HOMA2-IR was linked to higher CV mortality in obese participants compared to the middle group (adjusted hazard ratio, 1.82, 95% confidence interval, 1.14–2.92, P = 0.013). The results from the restricted cubic spline analysis displayed a J-shaped correlation between HOMA2-IR and all-cause, as well as CV mortality. Additionally, a nonlinear U-shaped correlation was observed in the obese population, with inflection points identified at 1.64 and 1.85. Below these inflection points, a negative relationship between HOMA2-IR and mortality was observed. Conclusions Elevated HOMA2-IR demonstrated a noteworthy correlation with escalated risks of both all-cause and CV mortality. It was noteworthy that excessively diminished levels of insulin resistance exhibited a distinct association with heightened mortality among obese individuals.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a cohort in Obesity (n=7,085). Low HOMA2-IR (≤ 1.0) vs. Moderate HOMA2-IR (1.0-2.0) was evaluated on Cardiovascular mortality in obese participants (HR 1.82, 95% CI 1.14-2.92, p=0.013). In obese individuals, excessively low levels of insulin resistance (HOMA2-IR ≤ 1.0) were associated with a significantly higher risk of cardiovascular mortality compared to moderate levels (HR 1.82).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: